Kyle Kim, Michele M Kim, Giorgos Skoufos, Eric S Diffenderfer, Seyyedeh Azar Oliaei Motlagh, Michail Kokkorakis, Ilektra Koliaki, George Morcos, Khayrullo Shoniyozov, Joanna Griffin, Artemis G Hatzigeorgiou, James M Metz, Alexander Lin, Steven J Feigenberg, Keith A Cengel, Bonnie Ky, Constantinos Koumenis, Ioannis I Verginadis
PURPOSE: Studies during the past 9 years suggest that delivering radiation at dose rates exceeding 40 Gy/s, known as "FLASH" radiation therapy, enhances the therapeutic index of radiation therapy (RT) by decreasing normal tissue damage while maintaining tumor response compared with conventional (or standard) RT. This study demonstrates the cardioprotective benefits of FLASH proton RT (F-PRT) compared with standard (conventional) proton RT (S-PRT), as evidenced by reduced acute and chronic cardiac toxicities...
February 15, 2024: International Journal of Radiation Oncology, Biology, Physics